Horizon Therapeutics

ACTIMMUNE

Manufacturer:

Horizon Therapeutics

Actimmune HCPCS:

J9216

HCPCS Code Descriptor:

Injection, interferon, gamma 1-b, 3 million units

Category:

J Code

Actimmune NDCs:

75987-0111-11, 75987-0111-10

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Actimmune:

ACTIMMUNE is an Oncology drug manufactured by Horizon Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9216 is aligned to the drug ACTIMMUNE.

ACCESS PRICING AND MORE BY REGISTERING

J9216 Added Date:

January 1, 1993

J9216 Effective Date:

January 1, 2019

J9216 Termination Date:

HCPCS Active

Actimmune billing and coding information can be found through Horizon Therapeutics at the link below:
Actimmune patient assistance information can be found through Horizon By Your Side at the URL: https://www.horizontherapeutics.com/patients/patient-support
ACTIMMUNE prescribing information can be found at the link below:
Information regarding ACTIMMUNE’s side effects can be found at MedlinePlus